RT Conference Proceedings
T1 Lurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trials
A1 Ponce, S.
A1 Calvo, E.
A1 De Miguel, M. J.
A1 Sessa, C.
A1 Flor, M. J.
A1 Drilon, A.
A1 Falcon, A.
A1 Sanchez Simon, I.
A1 Nunez, R.
A1 Luepke, X. E.
A1 Cuevas-Melendez, N.
A1 Lopez-Vilarino, J.
A1 Fudio, S.
A1 Siguero, M.
A1 Cullell-Young, M.
A1 Kahatt, C.
A1 Zeaiter, A.
A1 Paz-Ares, L.
K1 SCLC
K1 Lurbinectedin
K1 Combination
PB Elsevier science inc
SN 1556-0864
YR 2019
FD 2019-10-01
LK https://hdl.handle.net/10668/27252
UL https://hdl.handle.net/10668/27252
LA en
DS RISalud
RD Apr 8, 2025